Syndax to host ash investor event in person and via webcast on december 8, 2025

New york, nov. 03, 2025 (globe newswire) -- syndax pharmaceuticals (nasdaq: sndx), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that the company will host an in-person investor event, along with a live webcast, on monday, december 8, 2025, at 7:00 a.m. et during the 67th american society of hematology (ash) annual meeting.
ASH Ratings Summary
ASH Quant Ranking